Your side effect profile will remain exactly what it would have been on your normal schedule
What is tooth bonding
It has been licensed for aiding weight loss in non-diabetic people under the trade name Wegovy, strictly indicated for patients with obesity or overweight with diagnosed weight-related comorbidities [6, 7]
Injectable Semaglutide has not been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
Research suggests that some people may regain weight after stopping Wegovy
(, , )